Search

Author/Creator Guillon, Gilles

1. Pharmacological characterization of FE 201874, the first selective high affinity rat V1A vasopressin receptor agonist. (27th August 2013)

Authors:
Marir, Rafik; Virsolvy, Anne; Wisniewski, Kazimierz; Mion, Julie; Haddou, Dominique; Galibert, Evelyne; Meraihi, Zahia; Desarménien, Michel G; Guillon, Gilles
Journal:
British journal of pharmacology
Issue:
Volume 170:Number 2(2013:Sep.)
Page Start:
278
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Terlipressin, a vasoactive prodrug recommended in hepatorenal syndrome, is an agonist of human V1, V2 and V1B receptors: Implications for its safety profile. (November 2016)

Authors:
Colson, Pascal H.; Virsolvy, Anne; Gaudard, Philippe; Charrabi, Azzouz; Corbani, Maithé; Manière, Maxime J.; Richard, Sylvain; Guillon, Gilles
Journal:
Pharmacological research
Issue:
Volume 113(2016:Nov.)Part A
Page Start:
257
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Vasopressin and oxytocin expression in hypothalamic supraoptic nucleus and plasma electrolytes changes in water-deprived male Meriones libycus. Issue 5 (3rd September 2021)

Authors:
Boumansour, Lydia; Benhafri, Nadir; Guillon, Gilles; Corbani, Maithe; Touati, Hanane; Dekar-Madoui, Aicha; Ouali-Hassenaoui, Saliha
Journal:
Animal cells and systems
Issue:
Volume 25:Issue 5(2021)
Page Start:
337
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗